Cashu Logo
HomeWatchlistNewsSignalsPicks
DJI
-0.20%
SPX
-0.64%
IXIC
-1.15%
FTSE
-0.32%
N225
-0.26%
AXJO
-0.08%
Cashu Logo
Log In
HomeWatchlistNewsSignalsPicks
Stocks
0.00 (0.00%)
0.000
USD
At close at --,----
Cashu Logo Alt
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.

Company

  • About Us
  • Careers
  • Blog
  • News

Help & Support

  • Help Center
  • Contact Us
  • Pro Support

Legal

  • Privacy Policy
  • Terms of Use
InstagramYouTube

© 2024 Cashu PTY LTD.

Join our newsletter to keep up to date with us!

Overview

Loading chart...

Recently from Cashu

publisher logo
Cashu

BioMarin Pharmaceutical to Showcase Innovations at Key September Healthcare Conferences

3 days ago
publisher logo
Cashu

Biomarin Pharmaceutical: Leading Innovation in Rare Disease Therapies and Gene Treatments

14 days ago
publisher logo
Cashu

BioMarin Pharmaceutical Sees Positive Shift in Investor Sentiment, Short Interest Decreases

17 days ago

Key Stats

Market Cap
11.17B
Dividend Yield
0.00%
P/E Ratio
17.00
EPS
2.25
Revenue
2.85B
Avg. Volume
1.63M

About

What does BMRN do?
BioMarin Pharmaceutical, headquartered in San Rafael, California, develops therapies for serious rare diseases and employs 3,401 people. Its products include Vimizim, Roctavian, and Voxzogo for various medical conditions.
Sector
💻 Health Care
IPO
CEO
Employees
3,040
Headquarters
California, USA
Website
http://www.biomarin.com
Stocks
Health Care
bmrn
Biomarin Pharmaceutical
NASDAQ: BMRN
+0.60 (+1.04%)
58.28
USD
At close at Aug 29, 20:37 UTC
Summary
News
Signals
Benchmarks
Financials